Acceleron Pharma
Acceleron Pharma, Inc. is a public American "clinical stage biopharmaceutical company" based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
Wikipage redirect
primaryTopic
Acceleron Pharma
Acceleron Pharma, Inc. is a public American "clinical stage biopharmaceutical company" based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
has abstract
Acceleron Pharma, Inc. is a pu ...... scle, bone, and blood vessels.
@en
founding year
number of employees
revenue ($)
Wikipage page ID
42,358,544
page length (characters) of wiki page
Wikipage revision ID
1,019,213,453
Link from a Wikipage to another Wikipage
footnotes
Key People
@en
industry
Biotechnology
@en
location city
location country
United States
@en
logo
@en
name
Acceleron Pharma, Inc.
@en
num employees
revenue
$74.5 million for FY2017
@en
traded as
NASDAQ:XLRN
@en
wikiPageUsesTemplate
subject
comment
Acceleron Pharma, Inc. is a pu ...... scle, bone, and blood vessels.
@en
label
Acceleron Pharma
@en
sameAs
wasDerivedFrom
isPrimaryTopicOf
name
Acceleron Pharma, Inc.
@en